VanEck Vectors Morningstar Durable Dividend ETF DURA 深 沪
等待开盘 11-10 09:30:00 美东时间
40.371
+0.375
+0.94%
华盛通- 最 高40.479
- 今 开40.14
- 成交量 1216股
- 最 低 40.14
- 昨 收 39.9964
- 总市值 3835.25万
- 52周最高 41.47
- 市盈率 静 --
- 换手率 0.13%
- 52周最低 32.1653
- 委 比 0.00%
- 总股本 95.00万
- 历史最高 41.47
- 量 比 1.03
- 振 幅 0.85%
- 历史最低 12.7881
- 每 手 1
- 风险率 2.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Rocky Mountain Chocolate Factory Announces Houston Airport Store Opening and Aspen Lease Signing
Rocky Mountain Chocolate Factory (RMCF) has opened a new store in Houston's George Bush Intercontinental Airport and signed a lease for a future location in Aspen, Colorado. These moves align with RMCF's strategy to expand in high-traffic travel environments and destination markets. The Houston store marks the sixth company-owned location, while Aspen, a natural fit for the Colorado-founded brand, will enhance its presence in a major mountain des...
11-09 13:30
EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026
EyePoint, Inc. (Nasdaq: EYPT) will host a conference call on November 12, 2026, at 8:30 a.m. ET to discuss its Q3 2026 financial results and recent developments. The call will be accessible via a live webcast on the Company's website, with a replay available afterward. EyePoint focuses on developing innovative therapeutics for retinal diseases, with its lead product, DURAVYU™, in Phase 3 trials for diabetic macular edema. The company is headquart...
11-05 12:00
Phathom Pharmaceuticals Announces Eligible Commercially Insured Patients May Now Pay as Little as $0 for VOQUEZNA® (vonoprazan) Tablets Exclusively at BlinkRx
Phathom Pharmaceuticals has announced a $0 copay offer for VOQUEZNA tablets through BlinkRx for eligible commercially insured patients, simplifying access to treatment for GERD. The program includes free home delivery, prior authorization support, and easy refills. Patients without insurance can use a cash-pay option. VOQUEZNA is approved for treating erosive esophagitis and heartburn associated with GERD. For more details, visit www.VOQUEZNA.com...
11-03 13:00
EyePoint Announces Strategic Prioritization
EyePoint, Inc. announced strategic adjustments to reduce operating expenses and focus on its late-stage DURAVYU program for diabetic macular edema (DME) after the Phase 3 LUCIA study in wet AMD did not meet its primary endpoint, despite improvements in vision and treatment burden reduction. The company plans to reduce its workforce by approximately 53% and end wet AMD trials early to conserve capital and prioritize DME development. DURAVYU is exp...
10-19 11:15
EyePoint Announces Topline Results from LUCIA, the Second Pivotal Phase 3 Clinical Trial of DURAVYU™ in Wet AMD
EyePoint announced topline results from the LUCIA Phase 3 trial of DURAVYU for wet AMD. While visual improvement was demonstrated, the primary endpoint of statistical non-inferiority in BCVA change vs. aflibercept was not met. Key secondary endpoints were achieved, including a 38% reduction in treatment burden and strong anatomic control. The favorable safety profile was maintained. The DME program remains on track with Phase 3 data expected in Q...
10-19 11:00
VanEck Vectors Morningstar Durable Dividend ETF declares quarterly distribution of $0.2609
VanEck Vectors Morningstar Durable Dividend ETF (DURA) - $0.2609. Payable Oct 06; for shareholders of record Oct 01; ex-div Oct 01. More on VanEck ETF Trust - VanEck Morningstar Durable Dividend ETF S...
10-02 04:19
A股盘前市场要闻速递（2026-08-19）
小程序：A股盘前市场要闻速递 重要新闻 1. 重大突破，我国首次实现火箭陆地回收 今天（8月19日），朱雀三号遥二运载火箭在东风商业航天创新试验区发射升空，火箭...
08-19 09:02
EyePoint rebounds after selloff despite multiple downgrades
After losing more than 65% in the previous session following a late-stage trial setback for its lead asset, Duravyu, EyePoint added 7% in morning trading despite facing multiple downgrades on Wall Str...
08-18 22:17
跨界牛股13天12板后提示风险：可能申请停牌核查 | 盘后公告精选
13天12板妖股再发异动公告，3000亿存储芯片龙头上半年净利大爆发，这一CPO概念股拿下8.68亿元算力采购合同......
08-18 21:11
